Oncology CME

Credits: 1.00 CME / CNE
Penn State College of Medicine
Advances in Precision Care in Solid Tumor Oncology: Defining the Role of PARP Inhibitors
Robert Coleman, MD
8 November, 2019
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Composing Personalized HCC Treatment Strategies: Insights on Harmonizing Patient Care With a Multidisciplinary Ensemble
Ghassan Abou-Alfa, MD, MBA
4 November, 2019
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Challenges, Controversies, and Opportunities in the Management of EGFR-Mutant Lung Cancer With Central Nervous System Metastases: Working Together to Improve Patient Outcomes
Kathryn Beal, MD / Sandip Patel, MD
4 November, 2019
Credits: 1.00 CNE
Medical Learning Institute, Inc.
Identification, Triage, and Management of Immune-Related Adverse Effects in Patients With Cancer Presenting to the Emergency Department: Practical Guidance for Emergency Nurses
Sorayah Bourenane, MSN, RN, CNL / Marianne Davies, DNP, ACNP, AOCNP
29 October, 2019
Credits: 1.50 CME
Penn State College of Medicine
Innovative Therapy for B-Cell Malignancies: A MasterClass and Tumor Board on Decision-Making in CLL, FL, and MCL
Ian W. Flinn, MD, PhD
28 October, 2019
Credits: 1.00 CME / MOC / CC
Medical Learning Institute, Inc.
Pathology Insights on Innovation in AML: The Rapid Emergence of Precision Diagnostics & Novel Therapy Across the Spectrum of Care
Carlos E. Bueso-Ramos, MD, PhD
28 October, 2019
Credits: 1.50 CME
Medical Learning Institute, Inc.
Readying the Modern Radiation Oncology Practice for Incorporation of a Fourth Modality in Cancer Treatment: Understanding the Science, Evidence & Clinical Application Across a Range of Solid Malignancies
Matthew T. Ballo, MD, FACR
23 October, 2019
Credits: 1.50 CME / MOC / CC
Medical Learning Institute, Inc.
A Pan-Cancer, Pan-Biomarker Exploration of the Opportunities to Realize the Potential of Precision Immuno-Oncology: Are Pathology Professionals Ready for the Challenge?
Lynette M. Sholl, MD
23 October, 2019
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
NSCLC Tumor Board: Navigating the Evolving Role of Immunotherapy in Multimodal Management of Locally Advanced and Early-Stage Lung Cancer
Roy H. Decker, MD, PhD
21 October, 2019
Credits: 1.00 CNE
Medical Learning Institute, Inc.
The Urologic Nurse Meets the Challenge of Renal Cell Carcinoma: Insights on Patient Care in an Expanding Treatment Landscape
Julia Batten, APRN, MSN, MPH / Virginia J. Seery, MSN, RN, ANP-BC
17 October, 2019
Credits: 0.50 CME / MOC / CNE
Medical Learning Institute, Inc.
The Oncology Team and Secondary AML: Conversations on New Science and Its Effect on Patient Care
Stephen A. Strickland, MD, MSCI
18 September, 2019
Credits: 1.00 CME / CNE
Penn State College of Medicine
Driving Change in Multiple Myeloma: Updates on Novel Agent Classes and Next-Generation Therapeutics
Robert Z. Orlowski, MD, PhD
8 August, 2019
Credits: 0.75 CME / MOC / CNE
Medical Learning Institute, Inc.
Expanding Treatment Choices in Mesothelioma: Exploring the Promise of Tumor Treating Fields and Novel Systemic Approaches to Optimize Patient Outcomes
Charles B. Simone, MD, FACRO
29 July, 2019
Credits: 1.50 CME
Medical Learning Institute, Inc.
Candid Conversations About NSCLC—Live From Chicago: Navigating Immunotherapies and Combinations in the Search for the Best Strategy for Each Patient
Benjamin Levy, MD
25 July, 2019
Credits: 2.00 CME / MOC / CNE
Medical Learning Institute, Inc.
Stories From the Pancreatic Cancer CaseBook: Taking the Road to Improved Outcomes With Modern Therapeutic Concepts and Innovative Treatments
Johanna C. Bendell, MD
22 July, 2019
Credits: 2.00 CME / MOC
Medical Learning Institute, Inc.
‘How I Think, How I Treat’—Embarking on a New Treatment Era in Hepatocellular Carcinoma: A Personal Take on Integrating Recent Evidence Into the Continuum of Care for Patients With HCC
Ghassan Abou-Alfa, MD, MBA
19 July, 2019
Credits: 0.50 CME
Penn State College of Medicine
Taking a New Look at Mantle Cell Lymphoma in the Era of Novel Agent Classes: From Innovative Concepts to Practical Applications of Evidence
John Allan, MD
17 July, 2019
Credits: 1.50 CME
Penn State College of Medicine
New Concepts in Prostate Cancer Care: What Oncologists Need to Know to Optimize Patient Outcomes
Robert Dreicer, MD, MS, MACP, FASCO
16 July, 2019
Credits: 2.00 CME
Penn State College of Medicine
A MasterClass on Innovative Therapy in B-Cell Lymphoma: Evidence, Clinical Guidance, and Insights on the Future of Patient Care
Nathan H. Fowler, MD
3 July, 2019
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Redefining the Management of Advanced RCC: An Expert Tumor Board on Rational Selection, Sequencing, and Combination of Targeted Agents and Immunotherapy
David F. McDermott, MD
3 July, 2019
Credits: 1.50 CME / MOC / CNE
Medical Learning Institute, Inc.
Mapping Progress With Immune Checkpoint Inhibitors in Head and Neck Cancer: Expert Views on Immunotherapy as a Component of Multimodal Care
Ezra Cohen, MD, FRCPSC, FASCO
2 July, 2019
Credits: 1.00 CME / CNE / CPE
Medical Learning Institute, Inc.
Beyond the Basics of Immuno-Oncology: Navigating Clinical Challenges to Maximize the Benefits and Minimize the Risks of Cancer Immunotherapies
Evan J. Lipson, MD
26 June, 2019
Credits: 0.50 CME / MOC / CNE / CPE
Medical Learning Institute, Inc.
Taking a New Look at Cancer-Associated Venous Thromboembolism: How Is Emerging Evidence Influencing Guidelines & Practice?
Robert D. McBane, MD
25 June, 2019
Credits: 1.50 CME / MOC
Medical Learning Institute, Inc.
Changing the Treatment Story in Myelofibrosis: New Science and More Choices for Challenging Cases in the JAK Inhibitor Era
Professor Claire Harrison, MD
25 June, 2019
Credits: 1.00 CME / CNE / CPE
Penn State College of Medicine / Medical Learning Institute, Inc.
The Emergence of Oral Therapy as a Pillar of Care in B-Cell Lymphoma: Insights and Expert Opinions From the Hematology-Oncology Team
Nathan H. Fowler, MD
21 June, 2019
Credits: 1.50 CME / MOC / CNE
Medical Learning Institute, Inc.
The Expanding Role of Immunotherapy in Locally Advanced and Earlier Stages of Lung Cancer: Rationale, Current Evidence, Key Trials, and Implications for Thoracic Surgeons
Jessica Donington, MD
17 June, 2019
Credits: 1.50 CME
Penn State College of Medicine
Advancing the Management of Urothelial Cancer With Immuno-Oncology and Targeted Approaches: Key Concepts for Urology Professionals on the Front Lines of Care
Neal D. Shore, MD, FACS
6 June, 2019
Credits: 1.25 CME / MOC / CNE
Medical Learning Institute, Inc.
On the Cusp of the Era of Immuno-Oncology in Triple-Negative Breast Cancer: Rational Strategies to Make the Most of Immunotherapies and Other Effective Treatment Modalities Throughout the Disease Continuum
Elizabeth A. Mittendorf, MD, PhD
3 June, 2019
Credits: 1.00 CME / MOC / CNE
Medical Learning Institute, Inc.
A New Era Has Begun in the Treatment of SCLC: Navigating Novel Therapeutic Options and Strategies for Improving Patient Outcomes
Stephen V. Liu, MD
29 May, 2019
Credits: 1.50 CNE
Medical Learning Institute, Inc.
Navigating the CAR-T Cell Therapy Landscape in Hematologic Malignancies: Science and Practical Issues in Nursing Care
Susan Blumel, RN, BSN
24 May, 2019

Pages